HomeInsightsPB

Bafna Pharmaceuticals Ltd PB Ratio

Bafna Pharmaceuticals Ltd PB Ratio

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.7 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

PB

2.3

Last updated: 18 Sep 24

Key Highlights

  • The P/B Ratio of Bafna Pharmaceuticals Ltd is 2.3 as of 18 Sep 24.
  • The P/B Ratio of Bafna Pharmaceuticals Ltd changed from 4.8 on March 2022 to 2.2 on March 2024 . This represents a CAGR of -22.90% over 3 years. .

Historical P/B Ratio of Bafna Pharmaceuticals Ltd

No data available

Company Fundamentals for Bafna Pharmaceuticals Ltd

Market Cap

185 Cr

EPS

0.3

P/E Ratio (TTM) *

301.9

P/B Ratio (TTM) *

2.3

Day’s High *

78.5

Day’s Low

77.0

DTE *

0.3

ROE *

9.1

52 Week High

112.2

52 Week Low

73.35

ROCE *

9.0

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Bafna Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 202478.5
17 Sep 202478.62
16 Sep 202481.43
13 Sep 202479
12 Sep 202479.97
11 Sep 202481.5
10 Sep 202481.5
09 Sep 202477.74
06 Sep 202479.6
04 Sep 202479.55

SWOT Analysis Of Bafna Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bafna Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bafna Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Key Valuation Metric of Bafna Pharmaceuticals Ltd

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend per Share (DPS) Over Time

No data available

Bafna Pharmaceuticals Ltd News Hub

News

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

05 Sep 202410:29

News

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

04 Sep 202417:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

10 Aug 202413:56

News

Bafna Pharmaceuticals to hold board meeting

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 M...

Read more

28 May 202413:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

03 Feb 202414:11

News

Bafna Pharmaceuticals announces board meeting date

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

01 Nov 202317:06

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PB Ratio of Bafna Pharmaceuticals Ltd

What is the PB ratio of Bafna Pharmaceuticals Ltd?

The current PB ratio of Bafna Pharmaceuticals Ltd is 2.3. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Bafna Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Bafna Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Bafna Pharmaceuticals Ltd calculated?

The PB ratio of Bafna Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Bafna Pharmaceuticals Ltd?

A high PB ratio suggests that Bafna Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Bafna Pharmaceuticals Ltd?

A low PB ratio of Bafna Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Bafna Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Bafna Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*